JNJ

Johnson & Johnson

Healthcare
255.56 +2.28 +0.90% Pre-Market
2026-10-16 • USD

Key Metrics

Market Cap 615.87B
EV 644.15B
Shares Out 2.41B
Revenue (ttm) 97.93B
Net Income 21.04B
Beta —
P/E —
Forward P/E —
EPS (ttm) $8.61
P/S 6.28
P/B 7.24
P/FCF 27.66
P/C 22.28
EV/Sales 6.58
EV/EBITDA —
ROA 10.46%
ROE 25.74%
ROIC —
Gross Margin 67.91%
Oper. Margin —
Profit Margin 21.48%
Debt/Eq 0.58
LT Debt/Cap 30.53%
Quick Ratio 0.73
Current Ratio 1.09
Book/sh 35.3
Cash/sh 8.48
Div Yield 2.05%
Div TTM $5.24
Payout Ratio 60.86%
SMA20 -2.23%
SMA50 -3.65%
SMA200 4.69%
Volume 6,388,530
Avg Volume 7.59M
Rel Volume 0.84
Perf Week -3.10%
Perf Month -5.34%
Perf Quarter 1.00%
Perf Half Y 9.13%
Perf YTD 23.49%
Perf Year 32.26%
Perf 3Y 67.78%
Perf 5Y 55.95%

Factor Lens

Seasonal Performance

Dividends

Per-share amounts adjusted for stock splits.

Last Dividend $1.3400
TTM Yield 2.05%
TTM Amount $5.24
Payout Ratio 60.86%
3-Yr Growth (CAGR) 4.92%
5-Yr Growth (CAGR) 5.25%

Last 12 Payouts

Period Ex-Date Amount / Share
Q2 2026 ~2026-06-28 $1.3400
Q1 2026 ~2026-03-29 $1.3000
Q4 2025 ~2025-12-28 $1.3000
Q3 2025 ~2025-09-28 $1.3000
Q2 2025 ~2025-06-29 $1.3000
Q1 2025 ~2025-03-30 $1.2400
Q4 2024 ~2024-12-29 $1.2400
Q3 2024 ~2024-09-29 $1.2400
Q2 2024 ~2024-06-30 $1.2400
Q1 2024 ~2024-03-31 $1.1900
Q4 2023 ~2023-12-31 $1.1900
Q3 2023 ~2023-10-01 $1.1900

Financial Trends

Revenue & Net Income

Earnings Per Share

Margins

Cash Flow

Company Overview

Johnson & Johnson is a leading global healthcare company engaged in the research, development, manufacture, and sale of a wide range of products in three segments: Innovative…

Name
Johnson & Johnson
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Joaquin Duato · Chairman of the Board and Chief Executive Officer
Employees
130,000 as of 2025-12-28
IPO Date
2018-02-15
Phone
(732) 524-0400
Address
One Johnson & Johnson Plaza, New Brunswick, NJ 08933
Website
www.jnj.com

Key Executives

Name Title FY Pay
Deirdre Connelly Executive Vice President —
Peter Fasolo Executive Vice President —
James Young Executive Vice President —
Michael Ullem Vice President —
Joaquin Duato Chairman of the Board and Chief Executive Officer —

Latest News

Related stocks

Other companies in the same sector on MarketWalks.